InnoSer is an innovative and dynamic contract research organization supporting discovery and preclinical development of drugs.

Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting discovery and preclinical development of drugs. InnoSer’s offerings include a proprietary PDX/O screening platform for oncology, a unique ADPKD mouse model for nephrology, and a fully characterized midbrain organoid model for Parkinson’s disease. InnoSer also provides in vivo imaging, pathology and genetically engineered mouse model services including colony management, cryopreservation, and sanitation/rederivation.

Contact e-mail & tel: +32 (0)11 14 07 68

Website

LinkedIn

Twitter

Facebook

Check out our company introduction, download here